· rebuilt nightly from public records
Signal Sheet
Headquartered in Austin, Texas, Sensei Biotherapeutics is a publicly listed pharmaceutical preparations company. It raised $348.9M in Feb 2026 and its filings name 7 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Christopher Gerry | SEC filing, Feb 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Josiah Craver | SEC filing, Feb 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Anand Kiran Parikh | SEC filing, Feb 2026 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Tom Ricks | SEC filing, Feb 2026 | Technology and tooling decisions |
| Chief Technology Officer | Phillip B. Donenberg | SEC filing, Feb 2026 | Technology and tooling decisions |
| Chief Technology Officer | Bob Holmen | SEC filing, Feb 2026 | Technology and tooling decisions |
| Chief Technology Officer | Kristian Humer | SEC filing, Feb 2026 | Technology and tooling decisions |
Officer or director change
New leadershipEquity raise reported to the SEC, Feb 2026. Money arrives before the spending plan does.
CapitalEach with a title and the filing that names them, so the first call goes to the right desk.
PeopleThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 23, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 11, 2026 | Officer or director change | New leadership | SEC filing |
| Jul 21, 2026 | Officer or director change | New leadership | SEC filing |
| Feb 17, 2026 | Raised $348.9M in equity from 104 investors | Capital | SEC filing |
Lakewave finds the right people at Sensei Biotherapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Sensei Biotherapeutics with a free trial →| Headquarters | Austin, Texas, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Ownership | Listed company |
| Raise history | $348.9M (Feb 2026) |
| Lakewave Rising | 17 · 2 kinds of evidence · rank in Texas after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Sensei Biotherapeutics reported a $348.9M equity raise to the SEC on Feb 17, 2026 with 104 investors.
The company's SEC filing, Feb 2026 names Christopher Gerry (Executive Officer) among its officers.
Austin, Texas, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.